Strata Critical Medical, Inc. (SRTA)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Strata Critical Medical, Inc. reported revenue of $197.14M, up 34.3% from the prior year. The company was profitable, with a net margin of 21.0% and a gross margin of 20.9%. It held $325.47M in total assets against $46.40M in total liabilities.
Key ratios (FY2025)
20.9%
Gross margin
-11.3%
Operating margin
21.0%
Net margin
14.8%
Return on equity
+34.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $197.14M | $146.82M | $225.18M | $146.12M | $50.53M | $23.43M | $31.20M | — |
| Cost of Revenue | $156.01M | $117.23M | $183.06M | $123.84M | $40.01M | $21.11M | $26.50M | — |
| Gross Profit | $41.13M | $29.59M | — | — | — | — | — | — |
| Operating Income | -$22.35M | -$22.52M | -$68.12M | -$53.53M | -$24.09M | -$678.5K | -$11.54M | — |
| Net Income | $41.35M | -$27.31M | -$56.08M | -$27.26M | -$40.05M | -$20.52M | $2.33M | — |
| EPS (Diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 | $-0.40 | $-0.43 | — |
| Total Assets | $325.47M | $256.68M | $294.94M | $325.02M | $335.88M | $277.84M | $277.69M | — |
| Total Liabilities | $46.40M | $34.74M | $60.64M | $50.54M | $44.51M | $46.78M | $26.11M | — |
| Shareholders' Equity | $279.07M | $221.94M | $234.30M | $274.49M | $291.37M | $10.00M | $5.00M | $31.14M |
| Cash & Equivalents | $30.97M | $18.38M | $27.87M | $41.34M | $2.60M | $10.22M | $1.31M | — |
| Operating Cash Flow | -$48.91M | -$2.52M | -$32.35M | -$37.13M | -$15.62M | -$794.5K | -$10.30M | — |
| Capital Expenditures | $9.60M | $30.86M | $2.11M | $730.0K | $297.0K | $377.0K | $604.0K | — |
| Shares Outstanding | 82.09M | 77.50M | 73.52M | 71.24M | 42.88M | 25.21M | 25.14M | — |